Anzeige
Erschienen in:
01.01.2015 | Original Article
Nasal salmon calcitonin blunts bone microstructure alterations in healthy postmenopausal women
Erschienen in: Osteoporosis International | Ausgabe 1/2015
Einloggen, um Zugang zu erhaltenAbstract
Summary
In healthy postmenopausal women, nasal salmon calcitonin blunted distal radius and tibia bone microstructure degradation.
Introduction
Nasal salmon calcitonin (NSC) has been reported to lower vertebral fracture risk by 33 %, but to modestly increase spine areal bone mineral density (aBMD) by 1.5 %. Thus, NSC may also influence bone microstructure, another known determinant of bone strength.
Methods
In a randomized, double-blind, placebo-controlled trial, we investigated the effects of 200 IU/day NSC on distal radius and tibia bone microstructure (by high-resolution 3-dimensional peripheral quantitative computerized tomography), aBMD (by dual-energy X-ray absorptiometry), and serum bone turnover markers in healthy postmenopausal women.
Results
Mean age was 57.6 ± 0.8 (±SEM) and 57.4 ± 0.7 in NSC (n = 45) and placebo groups (n = 45), respectively. Mean femoral neck T-score was in the osteopenic range; prevalent vertebral fracture was 4 % in each group. There was no observed between-group difference in the primary outcome distal radius BV/TV (−2.8 ± 0.6 % vs. −4.3 ± 1.0 %, NS). By 2 years, the decrease in distal radius total density vs. baseline was 4.4 ± 0.7 % in controls and 2.1 ± 0.6 % in NSC-receiving patients (p < 0.05). Distal radius and tibia cortical thickness decreased by 3.7 ± 1.0 and 2.4 ± 0.5 % in placebo (p < 0.05 vs. baseline for both), respectively, but not in the NSC group. Distal radius total density and cortical thickness changes were lower in NSC group than in placebo (p < 0.05 for both) in the subgroup with baseline C-terminal telopeptides (CTX) above the median. By 6 and 12 months, serum CTX decreased by 17.3 ± 6.2 and 19.1 ± 6.6 % (both p < 0.05 vs. baseline), respectively, in NSC, but remained stable in controls (NS vs. baseline). There was no difference in aBMD. NSC was well tolerated, with less arthralgia than the placebo group (14 vs. 26, p < 0.05).
Conclusion
Nasal salmon calcitonin blunted the degradation of distal radius and tibia bone microstructure in healthy postmenopausal women.